SIRT3 and infection: The intracellular survival assays revealed that the SIRT3 KO BMDMs had significantly higher intracellular Mabc-S (multiplicity of infection [MOI] = 1 and 3) compared to the SIRT3 WT BMDMs (Figure 1(f)).